This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Legislation and regulations

Feb 21, 2025 - Announcement from the Centers for Medicare & Medicaid Services (CMS) of the approval of the Accreditation Commission for Health Care, Inc. (ACHC) for continued recognition as a national accrediting organization for home health agencies (HHAs) that wish to participate in the Medicare or Medicaid programs. This approval is applicable February 24, 2025, to February 24, 2031.
Source: Federal Register
Feb 21, 2025 - Announcement from the Centers for Medicare & Medicaid Services (CMS) of the approval of the American Association for Accreditation of Ambulatory Surgery Facilities, dba QUAD A, for continued recognition as a national accrediting organization for outpatient physical therapy providers that wish to participate in the Medicare or Medicaid programs. This approval is applicable April 4, 2025, to April 4, 2030.
Source: Federal Register
Feb 19, 2025 - Notice from the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) delaying the January 17, 2025, final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients" in accordance with the January 20, 2025, presidential memorandum titled "Regulatory Freeze Pending Review." These final rules will now be effective March 21, 2025. Comments regarding the delayed effective date are due by February 28, 2025.
Source: Federal Register
Feb 11, 2025 - Announcement from the Centers for Medicare & Medicaid Services (CMS) of receipt of an application for continued recognition of The Joint Commission as a national accrediting organization for hospitals that wish to participate in the Medicare or Medicaid programs. Comments are due by March 13, 2025.
Source: Federal Register
Feb 11, 2025 - Notice from the U.S. Department of Health and Human Services (HHS) delaying the effective date of the December 13, 2024, final rule in accordance with the January 20, 2025, presidential memorandum titled "Regulatory Freeze Pending Review." The final rule is now effective April 14, 2025, and the compliance date is also delayed until April 14, 2028.
Source: Federal Register
Jan 21, 2025 - Notice from the Indian Health Service amending the U.S. Department of Health and Human Services (HHS) Statement of Organization, Functions, and Delegations of Authority to reflect the reorganization of the IHS Office of Information Technology (GAG) and the Office Management Services (GAL).
Source: Federal Register
Jan 17, 2025 - Notice of final rule from the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) authorizing the Department of Veterans Affairs (VA) healthcare practitioners acting within the scope of their VA employment to prescribe controlled substances via telemedicine to a VA patient with whom they have not conducted an in-person medical evaluation. VA practitioners can prescribe controlled substances to VA patients if another VA practitioner has previously conducted an in-person medical evaluation of the VA patient at any time, subject to certain conditions. This final rule is effective February 18, 2025.
Source: Federal Register
Jan 17, 2025 - Notice of final rule from the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) amending their regulations to increase access to buprenorphine treatment for opioid use disorders (OUD) through a telemedicine encounter. This rule expands the circumstances under which individual providers are authorized to prescribe buprenorphine for OUD via telemedicine, including an audio-only telemedicine encounter. This final rule is effective February 18, 2025.
Source: Federal Register
Jan 17, 2025 - Notice of proposed rulemaking from the Drug Enforcement Administration (DEA) proposing regulatory changes aimed at expanding patient access to controlled substance medications via telemedicine while mitigating the risks of diversion associated with such expansion. Proposed changes would establish a Special Registration framework and authorize three types of Special Registration that would allow more comprehensive prescribing, including prescribing of Schedule II and narcotic and non-narcotic controlled substances in limited circumstances, by properly registered physicians and mid-level practitioners and dispensing by online telemedicine platforms that constitute covered online telemedicine platforms. Comments are due by March 18, 2025.
Source: Federal Register
Jan 15, 2025 - Notice from the Employee Benefits Security Administration (EBSA), Internal Revenue Service (IRS), and Department of Health and Human Services (HHS) withdrawing the October 28, 2024, notice of proposed rulemaking regarding coverage of certain preventive services under the Patient Protection and Affordable Care Act, which requires non-grandfathered group health plans and non-grandfathered group or individual health insurance coverage to cover certain contraceptive services without cost sharing. This withdrawal is effective January 15, 2025.
Source: Federal Register